Mast cell variations in tumour tissue and with histopathological grading in specimens of prostatic adenocarcinoma
- 1 November 1999
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 84 (7), 851-853
- https://doi.org/10.1046/j.1464-410x.1999.00245.x
Abstract
To determine whether the number of mast cells (MCs) varies in and around prostatic carcinoma tissue, and with histopathological grading. Specimens of 27 prostatic carcinomas were stained with the toluidine blue and staged histopathologically using the Gleason grading system. The MCs were counted in five high-power microscopy fields within and around the tissue samples, and the results analysed using the Wilcoxon signed-rank test and Spearman’s correlation. The mean number of MCs was 1.7 per field within and 3.31 per field around the cancer tissue, the difference between these being significant (Pr=0.56, P=0.002) but not between grade and counts around the tumour (r=−0.18, P=0.35). These results suggest that some MCs aggregate at the periphery of the prostatic adenocarcinoma and that the number of MCs within the tumour tissue is related to tumour differentiation.Keywords
This publication has 11 references indexed in Scilit:
- Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells.The Journal of Experimental Medicine, 1987
- Mast cells and matrix degradation at sites of tumour invasion in rat mammary adenocarcinomaBritish Journal of Cancer, 1986
- Tissue mast cells in breast cancerBreast Cancer Research and Treatment, 1985
- Growth of pulmonary metastases of B16 melanoma in mast cell-free miceJournal of Surgical Research, 1985
- Proliferation of mast cells in normal and DMBA-treated mouse skinJournal of Oral Pathology & Medicine, 1984
- Mast cells and metachromasia in human breast cancer: Their occurrence, significance and consequence: A preliminary reportThe Journal of Pathology, 1981
- Mast cell-mediated tumor-cell cytotoxicity. Role of the peroxidase system.The Journal of Experimental Medicine, 1981
- Evolutionary development of IgE and the role of anaphylactic-type reactions in resistance to solid tumoursCancer Immunology, Immunotherapy, 1978